NAM
AMRX icon

NorthCrest Asset Manangement’s Amneal Pharmaceuticals AMRX Stock Holding History

NorthCrest Asset Manangement’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$689K Buy
40,511
+83
+0.2% +$1.14K 0.02% 469
2026
Q1 		$505K Sell
40,428
-392
-1% -$5.26K 0.02% 473
2025
Q4 		$519K Buy
+40,820
New +$467K 0.01% 528

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

NorthCrest Asset Manangement's AMRX Position: Q2 2026 in Review

NorthCrest Asset Manangement increased its Amneal Pharmaceuticals (AMRX) stake by 0.21% in Q2 2026, buying an estimated $1.14K and bringing the position to 40,511 shares worth $689K. The position accounts for 0.02% of the portfolio, ranked #469.

NorthCrest Asset Manangement first reported a position in AMRX in Q4 2025 and has held it in 3 quarters since. 124 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • NorthCrest Asset Manangement held 40,511 shares of Amneal Pharmaceuticals worth $689K as of Q2 2026.
  • NorthCrest Asset Manangement bought 83 Amneal Pharmaceuticals shares in Q2 2026, an estimated $1.14K.
  • Amneal Pharmaceuticals made up 0.02% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #469 holding.
  • NorthCrest Asset Manangement first reported a position in Amneal Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 124 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.